Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

19

maj

3rd ATMP Mini‑Symposium: Lund 2026

19 maj 2026 12:00 till 17:05 | Övrigt
Graphic for the ATMP mini symposium Lund 2026

Join ATMP leaders from across Sweden as the 3rd ATMP Mini‑Symposium comes to Lund for the first time. This half‑day event offers a fast‑paced program of scientific talks, industry perspectives, and networking opportunities — an ideal forum for anyone working with or curious about emerging cell and gene therapies.

About the Event

We are pleased to welcome the 3rd ATMP Mini‑Symposium to Lund, following two highly successful editions at Karolinska Institutet and Uppsala University that drew more than 170 and 90 participants respectively. This year the event comes to southern Sweden, bringing together the national Advanced Therapy Medicinal Products (ATMP) community for an afternoon of scientific exchange, networking, and collaboration.

The symposium is organized by CCRM Nordic in partnership with Lund Stem Cell Center, the Lund University Pre‑GMP Facility, and the Strategic Research Area for Stem Cells and Regenerative Medicine (StemTherapy) — including both the Lund University and Uppsala University nodes.

Designed as an open and welcoming forum, the event invites researchers, industry professionals, clinicians, students, and others interested in ATMPs to join a half‑day program featuring 12 invited speakers from academia, hospitals, and industry.

Event Details:

Date: 19 May 2026
Time: 12:00–17:05
Location: LUX Aula, Helgonavägen 3, Lund University
Registration deadline: 05 May 2026
Registration link (Microsoft forms)

Programme Overview:

12:00–13:00 — Mingle Lunch

13:00 — Welcoming Remarks

13:05 - Scientific Sessions

  • 'Engineering tumor-specific cell-based immunotherapy' – Axel Hyrenius Wittsten, Lund University
  • 'Establishing a cellular therapy for ulcerative colitis' – Kim Jensen, University of Copenhagen
  • 'XSTEM toward disease‑modifying treatment for osteoarthritis' – Evy Lundgren‑Åkerlund, Xintela
  • 'A boomerang tour back TIL the future' – Jonas Nilsson, University of Gothenburg
  • 'BOOST Pharma: Stem cell treatment for Osteogenesis Imperfecta' – Lilian Walther Jallow, BOOST Pharma
  • 'GMP‑adapted immune modulatory extracellular vesicles for heart failure' – Karl‑Henrik Grinnemo, Uppsala University

14:35–15:15 — Fika

15:15 - Scientific Sessions

  • 'Lentivirus vectors for ex vivo and in vivo gene therapy' – Swaroop Krishna, CCRM Nordic
  • 'Ossigel: A first‑in‑class therapy for skeletal repair' – Dimitra Zacharaki, Dhalion Biotech
  • 'Industrial engineering of a life‑changing ATMP '– Petter Björquist, Verigraft
  • 'Engineering cell diversity for pain and regenerative dentistry models' – Pierfrancesco Pagella, Linköping University
  • 'Bridging biomarker discovery and digital monitoring in CAR T‑cell therapy' – Sara Ek, Lund University
  • 'AI‑supported quality control of ATMPs' – Jane Synnergren, University of Skövde

16:50 — Lund ATMP Infrastructures
17:05 — Closing Remarks

Event Registration:

This mini‑symposium is open to ATMP developers, researchers in academia and healthcare, industry professionals, students and early‑career scientists, as well as, anyone interested in cell and gene therapies, translational medicine, and emerging biotech innovation.

Participation is free, but registration is required. Please register by: Tuesday, 05 May 2026.

Om evenemanget

Plats:

LUX Aula, Helgonavägen 3, Lund University

Målgrupp:

Open to all

Språk:

in English

Kontakt:

Claire [dot] Mckay [at] med [dot] lu [dot] se